Sciome LLC

Biotech · Private

TOXGRAPH, a semantic knowledge graph system that maps adverse outcome pathways to quantitative biological data for toxicology risk assessment

Claim this profile

Follows are private to you and power your alerts

Updated · sciome.com

Sector
Biotech
Total capital
$41.9M
Federal grants
$2.5M
6 awards · 2017–2023
Rank in peer group#22 of 28
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$39.3M
16 awards · Environmental Prot, Health and Human S, Commerce
Rank in Biotech#21 of 4373
Granted patents
3
5 pending · first 2019
Rank in peer group#1 of 28

Capital timeline

20102014201820222026FEDERAL ↑EQUITY ↓Cumulative $41.9M$13.3M$1.4M$5.6M$3M$9.3M$5.5M
20102014201820222026FEDERAL ↑EQUITY ↓Cumulative $41.9M$13.3M$5.6M$9.3M$5.5M

Latest events

  • Federal contractHealth and Human S · EO14398 Evaluation And Conduct Of Computational And Alternative Toxicological Research For The National Institute Of Environmental Health Sciences. Contractor Conducts And Evaluates Toxicological Testing Using Computational And/or Alternative Approa$5.5M
  • Federal contractCommerce · Base Year Services, Non-personal For Swift-activescreener Enterprise Level Licenses$42K
  • Federal contractHealth and Human S · Bioinformatics Support For The National Institute Of Environmental Health Sciences (niehs) In Support Of Division Of Translational Toxicology (dtt) & Division Of Intermural Research (dir).$9.3M
  • Federal contractHealth and Human S · Bcbb Statistical Programming Support$3M
  • Federal grantHealth and Human S · Phase I · Research and development of an adverse outcome pathway-focused mechanistic inference tool for 'omics data using semantic knowledge graphs$250K
  • Federal contractHealth and Human S · Bioinformatics Support For Dntp & Dir$5.6M
  • Federal contractHealth and Human S · Sciome - Specialized Technical And Scientific Service$1.4M
Show 14 earlier federal awards
  • Federal contractCommerce · Nonpersonal Services For The Noaa Central Library (ncl) Requires An Enterprise Type License To Swift-active Screener$153K
  • Federal grantHealth and Human S · Phase II · Swift.ai: research and development of an integrated platform for machine-assisted research synthesis$828K
  • Federal contractEnvironmental Prot · A Gsa Task Order Supporting Development Of Data Extraction Models. The Extraction Model Consists Of A Series Of Computer Instructions, The Input Data Applied To Those Instructions, And The Output They Generate. Tasks Within This Current Pws Seek To C$285K
  • Federal contractHealth and Human S · Sciome - Specialized Technical And Scientific Service$748K
  • Federal contractCommerce · Purchase Of Annual Enterprise License For Swift-active Screener For The Noaa Central Library.$27K
  • Federal grantHealth and Human S · Phase II · Swift.ai: research and development of an integrated platform for machine-assisted research synthesis$820K
  • Federal grantHealth and Human S · Phase I · Research and development of an open, extensible, web-based information extraction workbench for systematic review$225K
  • Federal grantHealth and Human S · Phase I · SWIFT ActiveScreener research and development of an intelligent web based document screening system$212K
  • Federal grantHealth and Human S · Phase I · SWIFT-ActiveScreener: research and development of an intelligent web-based document screening system$212K
  • Federal contractHealth and Human S · Igf::ot::igf Bioinformatics Support For The Niehs In Dir&dntp$13.3M
  • Federal contractHealth and Human S · Igf::ot::igf Sciome Llc Dr. Christopher Wassif/ Dr. Forbes Porter, BLD-10CRC, RM-1-3288. BETHESDA-MD-20892 Standing Order For Bioinformatics Services As Needed Basis. Data Analys$25K
  • Federal contractHealth and Human S · Igf::ot::igf Bioinformatics Analysis Of Chip-seq Data$9K
  • Federal contractHealth and Human S · Igf::ot::igf Other Functions: Bioinformatics Analysis Of Chip-seq Data$18K
  • Federal contractEnvironmental Prot · Analysis Of Dna Sequencing Data$15K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 28 peers

Line = median

Biotech · Software

  • Federal grantsBelow median
  • Granted patents#1 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 8
Show all 8 patent records
  • OPHIREX, INCSimilar federal contract value in Biotech · $46.2M in contracts
  • METABOLON, INC.Similar federal contract value in Biotech · $42M in contracts
  • EITR BIOLOGICS, INC.Similar federal contract value in Biotech · $39.6M in contracts
  • Soligenix, IncSimilar federal contract value in Biotech · $39.1M in contracts
  • PROFECTUS BIOSCIENCES, INC.Similar federal contract value in Biotech · $38.3M in contracts
  • Argos TherapeuticsSimilar federal contract value in Biotech · $38.2M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .